Prognia
Drug Database
🇪🇺EU · EMAWithdrawnATC: B01AD07

Ecokinase(reteplase)

Myocardial Infarction

Marketing Authorisation Holder: Roche Registration Ltd.

EMA Authorisation: 29/08/1996

INN: reteplase

Indication

Thrombolytic therapy of acute myocardial infarction

Official EMA Resources

View on EMA (ema.europa.eu)

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about Ecokinase — dosing recommendations, drug interactions, and current guideline evidence from ESC, EMA, NICE and more.

Medical disclaimer: This information is intended for qualified healthcare professionals. Always verify with the official EMA Summary of Product Characteristics (SmPC) before clinical use.